Nevakar

About:

Nevakar is a specialty pharmaceutical company that focuses on the development of innovative products in the injectable and ophthalmic space.

Website: http://nevakar.com/

Top Investors: Novaquest Capital Management, Oxford Finance LLC, Armentum Partners

Description:

Nevakar is a specialty pharmaceutical company that focuses on the development of innovative products in the injectable and ophthalmic space. Their goal is to develop enhanced products that address unmet clinical and/or commercial needs of currently [FDA] approved molecules, through intensive R&D and clinical efforts. Nevakar’s business model is supported by state-of-the-art R&D infrastructure, located in the NJ Center of Excellence, and a well-experienced management and leadership team.

Total Funding Amount:

$135M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bridgewater, New Jersey, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)nevakar.com

Founders:

Navneet Puri

Number of Employees:

11-50

Last Funding Date:

2019-06-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai